Who are Polyunsaturated Fatty Acids's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Glucosamine/Chondroitin, Flax oil, N-acetyl-D-glucosamine, Cosamin DS® (Nutramax).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/polyunsaturated-fatty-acids.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Polyunsaturated Fatty Acids — Competitive Intelligence Brief

Polyunsaturated Fatty Acids (Polyunsaturated Fatty Acids) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Dietary supplement / Nutraceutical. Area: Cardiovascular.

marketed Dietary supplement / Nutraceutical Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Polyunsaturated Fatty Acids (Polyunsaturated Fatty Acids) — Hadir F. El-Dessouky. Polyunsaturated fatty acids (PUFAs) modulate inflammatory pathways and support cellular membrane integrity to reduce cardiovascular and metabolic disease risk.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Polyunsaturated Fatty Acids TARGET	Polyunsaturated Fatty Acids	Hadir F. El-Dessouky	marketed	Dietary supplement / Nutraceutical
Glucosamine/Chondroitin	Glucosamine/Chondroitin	Indus Hospital and Health Network	marketed	Dietary supplement / Nutraceutical
Flax oil	Flax oil	University of Rochester	marketed	Dietary supplement / Nutraceutical
N-acetyl-D-glucosamine	N-acetyl-D-glucosamine	Third Military Medical University	marketed	Dietary supplement / Nutraceutical
Cosamin DS® (Nutramax)	Cosamin DS® (Nutramax)	Eurofarma Laboratorios S.A.	phase 3	Dietary supplement / nutraceutical

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Dietary supplement / Nutraceutical class)

Hadir F. El-Dessouky · 1 drug in this class
Indus Hospital and Health Network · 1 drug in this class
Third Military Medical University · 1 drug in this class
University of Rochester · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Polyunsaturated Fatty Acids — Competitive Intelligence Brief. https://druglandscape.com/ci/polyunsaturated-fatty-acids. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab